Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Insect Venom Allergenic Extract [EPC]
Eriodictyon Californicum Flowering Top is a botanical source used in the production of allergenic extracts for the diagnosis and treatment of specific hypersensitivity reactions. It belongs to the class of non-standardized plant allergenic extracts.
Name
Eriodictyon Californicum Flowering Top
Raw Name
ERIODICTYON CALIFORNICUM FLOWERING TOP
Category
Standardized Insect Venom Allergenic Extract [EPC]
Drug Count
9
Variant Count
9
Last Verified
February 17, 2026
About Eriodictyon Californicum Flowering Top
Eriodictyon Californicum Flowering Top is a botanical source used in the production of allergenic extracts for the diagnosis and treatment of specific hypersensitivity reactions. It belongs to the class of non-standardized plant allergenic extracts.
Detailed information about Eriodictyon Californicum Flowering Top
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Eriodictyon Californicum Flowering Top.
Eriodictyon Californicum Flowering Top, commonly known in botanical circles as Yerba Santa ('holy herb'), is a species of plant native to the southwestern United States and Mexico. In the context of modern clinical pharmacology, it is primarily utilized as a source material for the production of allergenic extracts. According to the FDA's Established Pharmacologic Class (EPC) system, it is categorized under various headings, including Non-Standardized Plant Allergenic Extract [EPC], Standardized Chemical Allergen [EPC], and Non-Standardized Food Allergenic Extract [EPC]. These extracts are sterile liquids containing the water-soluble proteins and other constituents derived from the flowering tops of the plant.
Historically, Eriodictyon has been used in traditional medicine for respiratory conditions; however, its primary role in contemporary medicine is within the field of allergy and immunology. Healthcare providers utilize these extracts for two main purposes: the diagnosis of specific IgE-mediated allergies via skin testing and the treatment of allergic rhinitis or allergic asthma through allergen immunotherapy (hyposensitization). The FDA regulates these extracts through the Center for Biologics Evaluation and Research (CBER), ensuring that the manufacturing process follows strict Good Manufacturing Practices (GMP), even though many plant extracts remain 'non-standardized' compared to standardized venom or grass extracts.
The therapeutic mechanism of Eriodictyon Californicum Flowering Top extract depends on its clinical application. When used for diagnostic skin testing, a small amount of the extract is introduced into the skin (epicutaneous or intradermal). In individuals sensitized to the plant's proteins, specific Immunoglobulin E (IgE) antibodies bound to mast cells recognize the allergen, triggering the release of histamine and other inflammatory mediators. This results in a 'wheal and flare' reaction, allowing the clinician to confirm a specific allergy.
When used in allergen immunotherapy (AIT), the mechanism is significantly more complex. The goal is to induce immunological tolerance. By administering gradually increasing doses of the Eriodictyon extract, the immune system undergoes several key changes:
Unlike traditional small-molecule drugs, the pharmacokinetics of allergenic extracts like Eriodictyon Californicum Flowering Top are not measured through conventional plasma concentration studies. These substances are biological mixtures of proteins, glycoproteins, and polysaccharides.
Eriodictyon Californicum Flowering Top extracts are indicated for:
These extracts are typically supplied as sterile solutions in vials for parenteral use. They may be available in:
> Important: Only your healthcare provider can determine if Eriodictyon Californicum Flowering Top is right for your specific condition. The selection of specific allergens for testing and treatment must be based on a thorough clinical history and regional prevalence of the plant.
Dosage for Eriodictyon Californicum Flowering Top extract is highly individualized and is not based on a fixed milligram-per-kilogram scale. Instead, it is measured in Protein Nitrogen Units (PNU) or Weight/Volume (w/v) dilutions.
Immunotherapy consists of two distinct phases:
Eriodictyon Californicum Flowering Top extracts may be used in children, generally starting at age 5. Dosing protocols follow the same build-up and maintenance structure as adults, though healthcare providers may exercise greater caution during the build-up phase. The safety and efficacy in children under the age of 5 have not been extensively established, as the ability of very young children to communicate early symptoms of a systemic reaction is limited.
No specific dose adjustments are typically required for renal impairment, as the protein load is minimal. However, the patient's overall health and ability to tolerate a systemic reaction must be considered.
No dosage adjustments are defined for hepatic impairment.
Caution is advised in elderly patients, particularly those with underlying cardiovascular disease. The use of epinephrine (the primary treatment for a severe reaction) may be more risky in this population.
If a dose is missed during the build-up phase, the next dose may need to be reduced or the previous dose repeated to maintain safety. If a maintenance dose is missed for several weeks, the healthcare provider will typically reduce the dose and gradually build back up to the maintenance level. Never attempt to 'double up' on doses to make up for a missed appointment.
An overdose in the context of allergenic extracts usually refers to the administration of a dose higher than the patient's current tolerance level. This significantly increases the risk of a systemic allergic reaction or anaphylaxis.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Immunotherapy is a long-term commitment that requires strict adherence to the schedule for safety and effectiveness.
Most patients undergoing testing or treatment with Eriodictyon Californicum Flowering Top will experience local reactions. These are generally not dangerous but can be uncomfortable.
> Warning: Stop taking Eriodictyon Californicum Flowering Top and call your doctor immediately if you experience any of these symptoms of a systemic reaction or anaphylaxis.
There are no known long-term 'toxic' effects of Eriodictyon Californicum Flowering Top extract when used as directed. The primary long-term consideration is the successful modification of the immune system. In rare cases, patients may develop a persistent sensitivity or 'priming' where they become more sensitive to the allergen during peak pollination seasons, requiring temporary dose reductions.
While specific 'Black Box' text varies by manufacturer, all allergenic extracts like Eriodictyon Californicum Flowering Top carry a general warning regarding Anaphylaxis.
Report any unusual symptoms to your healthcare provider. Even a 'mild' systemic reaction (like a few hives) must be reported, as it may precede a much more severe reaction upon the next dose.
Eriodictyon Californicum Flowering Top extract is a potent biological product. Safety is predicated on the correct identification of the patient's sensitivity and the meticulous administration of the extract. Patients must be informed that immunotherapy does not provide immediate relief; it is a long-term disease-modifying therapy. The risk of a severe reaction is highest during the build-up phase and during periods of high environmental allergen exposure.
No FDA black box warnings for Eriodictyon Californicum Flowering Top specifically exist in the same format as high-risk pharmaceuticals like antidepressants; however, the class-wide warning for Allergenic Extracts is effectively a black box warning. It states: "Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylaxis. Patients should be observed for at least 30 minutes after administration. Do not administer to patients with unstable or severe asthma."
There is no evidence that Eriodictyon Californicum Flowering Top directly impairs the ability to drive. However, if a patient experiences a systemic reaction, dizziness, or significant fatigue after an injection, they should not operate machinery until symptoms have completely resolved.
Alcohol consumption should be avoided for several hours before and after an injection. Alcohol can increase blood flow to the skin (vasodilation) and may potentially accelerate the absorption of the allergen, increasing the risk of a reaction.
Immunotherapy is typically discontinued after 3 to 5 years of successful maintenance. There is no 'withdrawal' syndrome, but stopping prematurely may result in the return of allergy symptoms. If treatment is stopped due to a severe reaction, the healthcare provider will conduct a thorough risk-benefit analysis before deciding whether to restart at a much lower dose.
> Important: Discuss all your medical conditions with your healthcare provider before starting Eriodictyon Californicum Flowering Top, especially any history of heart disease or lung problems.
For each major interaction, the mechanism usually involves either the pharmacodynamic blocking of emergency rescue medications (beta-blockers) or the pharmacodynamic suppression of the diagnostic response (antihistamines). Management always involves a thorough medication review by the allergist before every injection.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter cold medicines.
Eriodictyon californicum is a member of the Boraginaceae family. Patients who are highly sensitive to other members of this family or related botanical extracts may show cross-reactivity during skin testing. This must be accounted for when interpreting results.
> Important: Your healthcare provider will evaluate your complete medical history, including your heart and lung health, before prescribing Eriodictyon Californicum Flowering Top.
Eriodictyon Californicum Flowering Top is generally categorized as Pregnancy Category C.
It is not known whether the allergenic proteins from Eriodictyon Californicum Flowering Top are excreted in human milk. However, because these are large proteins and the total dose administered is very small, it is highly unlikely that they would be absorbed by the nursing infant in significant quantities. Breastfeeding is generally not considered a contraindication to continuing immunotherapy.
Patients over age 65 require a careful cardiovascular assessment.
There are no specific guidelines for renal impairment. Since the dose is administered subcutaneously and consists of a very small amount of protein, it is not expected to impact or be impacted by kidney function significantly. However, patients with end-stage renal disease should be monitored for overall physiological stability.
No dosage adjustments are required for patients with liver disease. The metabolism of these proteins occurs through general proteolytic pathways rather than specific hepatic enzyme systems like the CYP450 system.
> Important: Special populations require individualized medical assessment and a cautious approach to the build-up phase of therapy.
At the molecular level, Eriodictyon Californicum Flowering Top extract works by introducing specific plant antigens to the immune system. In a sensitized individual, these antigens are captured by Dendritic Cells (antigen-presenting cells). These cells process the proteins and present them to Naive T-cells.
In the presence of the repeated, low-dose exposure characteristic of immunotherapy, the T-cells are signaled to differentiate into Regulatory T-cells (Tregs) instead of Th2 cells. These Tregs produce Interleukin-10 (IL-10) and Transforming Growth Factor-beta (TGF-β), which suppress the allergic inflammation. Furthermore, IL-10 signals B-cells to switch production from IgE to IgG4. IgG4 acts as a 'decoy' or 'blocking' antibody, binding the Eriodictyon allergens before they can reach the IgE on the surface of mast cells.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous administration) |
| Protein Binding | N/A |
| Half-life | Varies by protein component (hours for protein, years for immune memory) |
| Tmax | 30–60 minutes (for systemic absorption of allergens) |
| Metabolism | Proteolysis by tissue and plasma enzymes |
| Excretion | Renal (as peptide fragments) |
Eriodictyon Californicum Flowering Top extracts are complex biological mixtures. They contain various flavonoids (such as eriodictyol, homoeriodictyol, and sterubin), resins, and volatile oils, but the allergenic component is primarily the water-soluble protein fraction. The molecular weight of these proteins typically ranges from 10 to 70 kDa.
This agent is classified as a Non-Standardized Plant Allergenic Extract. Unlike 'Standardized' extracts (like certain grasses or ragweed), the potency of Eriodictyon extracts is not measured by a specific biological activity unit (like BAU) but is instead based on the weight of the raw material used or the total protein nitrogen content (PNU).
Common questions about Eriodictyon Californicum Flowering Top
Eriodictyon Californicum Flowering Top is primarily used in the medical field of allergy and immunology. It serves as a source for allergenic extracts used to diagnose and treat specific allergies to the Yerba Santa plant. Healthcare providers use it for skin prick testing to confirm if a patient is allergic to this specific botanical. If an allergy is confirmed and symptoms are severe, the extract is used in immunotherapy (allergy shots) to desensitize the patient's immune system over time. This process helps reduce symptoms of allergic rhinitis and asthma triggered by the plant.
The most common side effects are local reactions at the site of the injection or skin test. These include redness, itching, swelling, and a 'wheal' or bump that looks like a mosquito bite. These reactions usually appear within minutes and may last for a few hours or up to two days. Some patients may also experience mild fatigue or a temporary increase in their usual allergy symptoms, such as sneezing or nasal congestion, shortly after receiving an injection. While uncomfortable, these local reactions are generally not dangerous but should be monitored by your doctor.
It is strongly recommended to avoid alcohol consumption on the day of your allergy injection. Alcohol causes vasodilation, which is the widening of blood vessels, and can increase blood flow throughout the body. This may cause the injected allergen to be absorbed more quickly into your bloodstream, potentially increasing the risk of a systemic or 'whole-body' allergic reaction. Furthermore, alcohol can mask some of the early warning signs of a reaction, such as flushing or dizziness. Always follow the specific safety protocols provided by your allergy clinic regarding diet and lifestyle.
The safety of starting Eriodictyon Californicum Flowering Top immunotherapy during pregnancy has not been established, and it is generally avoided. The primary concern is the risk of anaphylaxis, which can cause a drop in blood pressure and oxygen levels that could be harmful to the developing fetus. However, if a patient is already on a stable maintenance dose and is tolerating the shots well, many allergists will continue the treatment throughout pregnancy. The decision is made on a case-by-case basis, weighing the benefits of allergy control against the risks of a reaction. Always inform your allergist immediately if you become pregnant.
For diagnostic purposes, the extract works almost immediately, providing results within 15 to 20 minutes of a skin test. However, when used as a treatment (immunotherapy), it takes much longer to see a clinical benefit. Most patients begin to notice a reduction in their allergy symptoms during the first year of treatment, usually after they have reached their maintenance dose. The full benefit of the therapy is typically achieved after the second or third year of consistent injections. Immunotherapy is a long-term 'disease-modifying' treatment rather than a quick-fix symptom reliever.
Yes, you can stop taking the injections suddenly without experiencing a 'withdrawal' syndrome like you might with some other medications. However, stopping immunotherapy before the recommended 3-to-5-year course is finished often means that your allergy symptoms will eventually return. The immune system requires a long period of exposure to the extract to 'learn' to be tolerant of the allergen. If you need to stop treatment due to side effects, financial reasons, or a move, you should discuss a plan with your allergist. They can advise you on the likelihood of your symptoms returning.
If you miss a scheduled allergy shot, you should contact your allergist's office as soon as possible to reschedule. Do not simply wait until your next regular appointment. The safety of the next dose depends on how much time has passed since your last injection. If too much time passes, your immune system's tolerance may have decreased, and your doctor may need to reduce your dose for the next few visits to prevent a reaction. Never attempt to administer the extract yourself or take extra doses to make up for the one you missed.
There is no clinical evidence to suggest that Eriodictyon Californicum Flowering Top allergenic extracts cause weight gain. Unlike systemic corticosteroids (such as prednisone), which are sometimes used to treat severe allergies and are well-known for causing weight gain, allergenic extracts work on a specific immunological pathway. The amount of protein and other substances in each injection is extremely small and does not affect your metabolism or appetite. If you experience unexpected weight gain while on this therapy, it is likely due to other factors or medications and should be discussed with your primary care physician.
Eriodictyon Californicum Flowering Top can be taken with many other medications, but there are some critical exceptions. You must inform your doctor if you are taking beta-blockers, ACE inhibitors, or certain types of antidepressants (MAOIs or TCAs), as these can make an allergic reaction more dangerous or harder to treat. Additionally, if you are having skin testing done, you must stop taking antihistamines for several days beforehand, as they will block the test's ability to show a reaction. Always provide your allergist with a complete and updated list of all your medications.
Allergenic extracts like Eriodictyon Californicum Flowering Top are biological products rather than simple chemical drugs, so the term 'generic' is not used in the traditional sense. Instead, different manufacturers may produce their own versions of the extract. While these extracts are all derived from the same plant species, they are 'non-standardized,' meaning the exact concentration of every protein may vary slightly between manufacturers. Because of this, allergists generally prefer not to switch between different brands of the same extract once a patient has started their treatment course to ensure safety and consistency.